Why the study?
Arterial hypertension is one of the most significant modifiable risk factors for stroke.
Does a fixed combination of amlodipine and ramipril improve blood pressure in a patient with hypertension and metabolic comorbidities?
Does a fixed combination of amlodipine and ramipril improve blood pressure in a patient with hypertension and metabolic comorbidities?
A fixed combination of amlodipine and ramipril demonstrated high antihypertensive efficacy in a patient with hypertension and multiple metabolic comorbidities.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for amlodipine-ramipril combination in metabolic comorbidities.
Arterial hypertension is one of the most significant modifiable risk factors for stroke. The article provides a clinical example of using a fixed combination of amlodipine + ramipril in real clinical practice in a patient suffering from arterial hypertension, occurring with dyslipidemia, hyperuricoemia, microalbuminuria. High antihypertensive activity of a fixed combination of amlodipine + ramipril was shown. A literature review of the beneficial effect of amlodipine and lisinopril on the risk of stroke, as well as the beneficial effect of this combination of drugs on the course of chronic kidney disease developing in patients with arterial hypertension, is presented.
No takes yet. Share an insight, caveat, or question.
Остроумова et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: